Haemonetics Corporation entered into a definitive agreement to acquire Opsens Inc. on October 10, 2023. Haemonetics will acquire all outstanding shares of OpSens for CAD $2.90 per share in an.
Medical technology company Haemonetics Corp. (HAE) and OpSens, Inc. (OPS.TO, OPSSF.PK) announced Tuesday that they have entered into a definitive agreement under which Haemonetics will acquire all outstanding shares of OpSens for C$2.
Quebec City heart technology maker OpSens Inc. has agreed to sell itself to Boston healthcare company Haemonetics Corp. for $345-million. It’s the biggest…
Opsens Inc. (T.OPS) hit a new 52-week high of $2.84 Tuesday. Opsens and Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, have entered into a .
Opsens Inc. (T.OPS) hit a new 52-week high of $2.84 Tuesday. Opsens and Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, have entered into a .